Cumberland Pharmaceuticals
CPIX
28 hedge funds and large institutions have $11.4M invested in Cumberland Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 27 → 28 (+1)
0.82% less ownership
Funds ownership: 26.62% → 25.81% (-0.82%)
12% less capital invested
Capital invested by funds: $12.9M → $11.4M (-$1.51M)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Berkshire Asset Management
Wilkes Barre,
Pennsylvania
|
+$501K |
| 2 |
Renaissance Technologies
New York
|
+$229K |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$117K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$4.89K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.21M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$96K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$51.7K |
| 4 |
Morgan Stanley
New York
|
-$11.1K |
| 5 |
BlackRock
New York
|
-$7.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$6K | -2,152 | Closed |
|
|
PWPS
27
Pinnacle Wealth Planning Services
Mansfield,
Ohio
| – | +$45 | +15 | New |
|
CPIX Hedge Fund Activity: Q4 2020 in Review
28 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2020, worth a combined $11.4M — down 12% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPIX positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Berkshire Asset Management, opening a new position worth an estimated $501K. The largest seller was Stonepine Capital Management, cutting an estimated $1.21M.
- 28 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2020, up from 27 in Q3 2020.
- Funds reported $11.4M of Cumberland Pharmaceuticals stock for Q4 2020, down 12% quarter-over-quarter.
- 3 funds opened new Cumberland Pharmaceuticals positions in Q4 2020 and 2 closed out, a net change of +1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q4 2020 was Berkshire Asset Management, an estimated $501K added.
- The largest Cumberland Pharmaceuticals seller in Q4 2020 was Stonepine Capital Management, an estimated $1.21M sold.
Based on aggregated 13F filings for Q4 2020.